glp-1 once weekly injection The risk of hair loss in patients taking drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. More details at the 🔗 in Glucagon-like peptide 1 (GLP-1) medications

Excited to continue on this journey of new improved me

Information to provide When the sensitivity started relative to starting retatrutide or changing your dose

Besouw MT, Holewijn S, Levtchenko EN, Janssen MC (2011) Non-invasive measurements of atherosclerosis in adult cystinosis patients

GPER1 mediates rapid signaling cascades involving adenylate cyclase, cyclic AMP, protein kinase A, and other second messengers

However by 24 weeks, carnitine users had increased muscle stores by 21% (see figure 1)

The findings obtained from the SMART collaborative meta-analysis (SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists), designed to evaluate the impact of SGLT2is on cardiovascular and renal outcomes based on the concomitant use or non-use of GLP1-RAs, included 12 controlled clinical trials with 73,238 participants, of whom 3065 (4.2%) received GLP1-RAs